Literature DB >> 12636166

Novel microemulsion enhancer formulation for simultaneous transdermal delivery of hydrophilic and hydrophobic drugs.

Philp J Lee1, Robert Langer, V Prasad Shastri.   

Abstract

PURPOSE: Microemulsion (ME) systems allow for the microscopic co-incorporation of aqueous and organic phase liquids. In this study, the phase diagrams of four novel ME systems were characterized.
METHODS: Water and IPM composed the aqueous and organic phases respectively, whereas Tween 80 served as a nonionic surfactant. Transdermal enhancers such as n-methyl pyrrolidone (NMP) and oleyl alcohol were incorporated into all systems without disruption of the stable emulsion.
RESULTS: A comparison of a W/O ME with an O/W ME of the same system for lidocaine delivery indicated that the O/W ME provides significantly greater flux (p < 0.025). The water phase was found to be a crucial component for flux of hydrophobic drugs (lidocaine free base, estradiol) as well as hydrophilic drugs (lidocaine HCl, diltiazem HCl). Furthermore, the simultaneous delivery of both a hydrophilic drug and a hydrophobic drug from the ME system is indistinguishable from either drug alone. Enhancement of drug permeability from the O/W ME system was 17-fold for lidocaine free base, 30-fold for lidocaine HCl, 58-fold for estradiol, and 520-fold for diltiazem HCl.
CONCLUSIONS: The novel microemulsion systems in this study potentially offers many beneficial characteristics for transdermal drug delivery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12636166     DOI: 10.1023/a:1022283423116

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

1.  An analysis of the size selectivity of solute partitioning, diffusion, and permeation across lipid bilayers.

Authors:  S Mitragotri; M E Johnson; D Blankschtein; R Langer
Journal:  Biophys J       Date:  1999-09       Impact factor: 4.033

2.  Microemulsions as topical drug delivery vehicles: in-vitro transdermal studies of a model hydrophilic drug.

Authors:  D W Osborne; A J Ward; K J O'Neill
Journal:  J Pharm Pharmacol       Date:  1991-06       Impact factor: 3.765

3.  Evaluation of penetration enhancement of lidocaine by nonionic surfactants through hairless mouse skin in vitro.

Authors:  P P Sarpotdar; J L Zatz
Journal:  J Pharm Sci       Date:  1986-02       Impact factor: 3.534

4.  Permeation of steroids through human skin.

Authors:  M E Johnson; D Blankschtein; R Langer
Journal:  J Pharm Sci       Date:  1995-09       Impact factor: 3.534

5.  Transdermal delivery of antiparkinsonian agent, benztropine. I. Effect of vehicles on skin permeation.

Authors:  S R Gorukanti; L Li; K H Kim
Journal:  Int J Pharm       Date:  1999-12-10       Impact factor: 5.875

6.  Transdermal dual-controlled delivery of contraceptive drugs: formulation development, in vitro and in vivo evaluations, and clinical performance.

Authors:  Y W Chien; T Y Chien; R E Bagdon; Y C Huang; R H Bierman
Journal:  Pharm Res       Date:  1989-12       Impact factor: 4.200

7.  The effect of temperature upon the permeation of polar and ionic solutes through human epidermal membrane.

Authors:  K D Peck; A H Ghanem; W I Higuchi
Journal:  J Pharm Sci       Date:  1995-08       Impact factor: 3.534

8.  Transdermal delivery of dideoxynucleoside-type anti-HIV drugs. 2. The effect of vehicle and enhancer on skin permeation.

Authors:  D D Kim; Y W Chien
Journal:  J Pharm Sci       Date:  1996-02       Impact factor: 3.534

9.  Enhancing effect of combining two pyrrolidone vehicles on transdermal drug delivery.

Authors:  H Sasaki; M Kojima; J Nakamura; J Shibasaki
Journal:  J Pharm Pharmacol       Date:  1990-03       Impact factor: 3.765

10.  A mechanistic study of the effects of the 1-alkyl-2-pyrrolidones on bilayer permeability of stratum corneum lipid liposomes: a comparison with hairless mouse skin studies.

Authors:  K Yoneto; S K Li; A H Ghanem; D J Crommelin; W I Higuchi
Journal:  J Pharm Sci       Date:  1995-07       Impact factor: 3.534

View more
  19 in total

1.  Evaluation of polymerized rosin for the formulation and development of transdermal drug delivery system: a technical note.

Authors:  Prashant M Satturwar; Suniket V Fulzele; Avinash K Dorle
Journal:  AAPS PharmSciTech       Date:  2005-12-27       Impact factor: 3.246

2.  Mass transport properties of progesterone and estradiol in model microemulsion formulations.

Authors:  Laura M Land; Ping Li; Paul M Bummer
Journal:  Pharm Res       Date:  2006-08-23       Impact factor: 4.200

3.  Investigation of the transdermal transport of charged local anesthetics in the presence of triterpene saponin glycosides.

Authors:  Christopher J Pino; Michael A Scherer; V Prasad Shastri
Journal:  Drug Deliv Transl Res       Date:  2014-04       Impact factor: 4.617

4.  Design and optimization of film-forming gel of etoricoxib using research surface methodology.

Authors:  Rabinarayan Parhi; V V Nishanth Goli
Journal:  Drug Deliv Transl Res       Date:  2020-04       Impact factor: 4.617

5.  Microemulsion microstructure influences the skin delivery of an hydrophilic drug.

Authors:  Wafa Naoui; Marie-Alexandrine Bolzinger; Bernard Fenet; Jocelyne Pelletier; Jean-Pierre Valour; Rafik Kalfat; Yves Chevalier
Journal:  Pharm Res       Date:  2011-03-25       Impact factor: 4.200

6.  Tween-embedded microemulsions--physicochemical and spectroscopic analysis for antitubercular drugs.

Authors:  S K Mehta; Gurpreet Kaur; K K Bhasin
Journal:  AAPS PharmSciTech       Date:  2010-01-20       Impact factor: 3.246

7.  Effect of formulation components on the in vitro permeation of microemulsion drug delivery system of fluconazole.

Authors:  Mrunali R Patel; Rashmin B Patel; Jolly R Parikh; Ajay B Solanki; Bharat G Patel
Journal:  AAPS PharmSciTech       Date:  2009-07-17       Impact factor: 3.246

8.  Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride.

Authors:  Hussein O Ammar; H A Salama; M Ghorab; A A Mahmoud
Journal:  AAPS PharmSciTech       Date:  2009-06-18       Impact factor: 3.246

9.  Nanocarrier for the transdermal delivery of an antiparkinsonian drug.

Authors:  Adnan Azeem; Farhan J Ahmad; Roop K Khar; Sushama Talegaonkar
Journal:  AAPS PharmSciTech       Date:  2009-09-09       Impact factor: 3.246

10.  Transdermal agomelatine microemulsion gel: pyramidal screening, statistical optimization and in vivo bioavailability.

Authors:  Mayada Said; Ibrahim Elsayed; Ahmed A Aboelwafa; Ahmed H Elshafeey
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.